Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sphenopalatine Ganglion Block for Post Spinal Headache
NCT03512977Completed
- Sponsor
- Derince Training and Research Hospital
- Start
- Dec 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine in post-dural puncture headache (PDPH) (2 arms), sponsored by Derince Training and Research Hospital. Primary endpoint: Visual Analog Scale Score at 24 hours. Started Dec 2017; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT03512977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03512977.